22/04/2026 (Agence Europe) – The European Commission has authorised the first combined vaccine against Covid-19 and seasonal flu for people aged 50 and over, it announced on Wednesday 22 April. The decision has been published in the Union Register of medicinal products. The vaccine, called mCombriax, is based on messenger RNA (mRNA) technology. It aims to provide simultaneous protection against the SARS-CoV-2 virus and three seasonal influenza strains. Severe forms of Covid-19 and...